141 related articles for article (PubMed ID: 28947869)
1. Clinical and pathological portraits of axillary presentation breast cancer and effects of preoperative systemic therapy.
Xu L; Li F; Liu Y; Duan X; Ye J; Cheng Y; Xin L
Chin J Cancer Res; 2017 Aug; 29(4):369-373. PubMed ID: 28947869
[TBL] [Abstract][Full Text] [Related]
2. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study.
He X; Ji J; Qdaisat A; Esteva FJ; Yeung SJ
Lancet Reg Health Am; 2024 Apr; 32():100712. PubMed ID: 38495316
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Jun; 45(6):969-975. PubMed ID: 30744944
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.
Aleman Espino A; Bernal IC; Guarecuco JE; El-Tawil R; Masri MM
Cureus; 2023 May; 15(5):e39583. PubMed ID: 37384084
[TBL] [Abstract][Full Text] [Related]
5. Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes.
Terada M; Adachi Y; Sawaki M; Hattori M; Yoshimura A; Naomi G; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Mori M; Horisawa N; Sasaki E; Yatabe Y; Iwata H
Breast Cancer Res Treat; 2018 Nov; 172(1):1-7. PubMed ID: 30030707
[TBL] [Abstract][Full Text] [Related]
6. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping.
Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C
Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239
[TBL] [Abstract][Full Text] [Related]
7. A Case Report of Male Occult Breast Cancer First Manifesting as Axillary Lymph Node Metastasis With Part of Metastatic Mucinous Carcinoma.
He M; Liu H; Jiang Y
Medicine (Baltimore); 2015 Jun; 94(25):e1038. PubMed ID: 26107674
[TBL] [Abstract][Full Text] [Related]
8. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
Mougalian SS; Hernandez M; Lei X; Lynch S; Kuerer HM; Symmans WF; Theriault RL; Fornage BD; Hsu L; Buchholz TA; Sahin AA; Hunt KK; Yang WT; Hortobagyi GN; Valero V
JAMA Oncol; 2016 Apr; 2(4):508-16. PubMed ID: 26720612
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features, psychological status, and prognosis of 33 patients with occult breast cancer.
Wang HM; Yu AY; Li LL; Ma LY; Cao MH; Yang YL; Qin XB; Tang JJ; Han ZX
World J Psychiatry; 2024 Jan; 14(1):76-87. PubMed ID: 38327892
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy.
Kang E; Chung IY; Han SA; Kim SM; Jang M; Lyou CY; Park SY; Kim JH; Kim YJ; Kim SW
J Breast Cancer; 2011 Jun; 14(2):147-52. PubMed ID: 21847411
[TBL] [Abstract][Full Text] [Related]
11. Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports.
Yang H; Li L; Zhang M; Zhang S; Xu S; Ma X
Medicine (Baltimore); 2017 Oct; 96(40):e8200. PubMed ID: 28984771
[TBL] [Abstract][Full Text] [Related]
12. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature.
Zhang Y; Wu D; Zhao B; Tian XL; Yao TC; Li F; Liu WF; Shi AP
World J Clin Cases; 2021 Feb; 9(4):919-926. PubMed ID: 33585640
[TBL] [Abstract][Full Text] [Related]
13. Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer.
Chen H; Meng X; Hao X; Li Q; Tian L; Qiu Y; Chen Y
J Immunol Res; 2022; 2022():7150304. PubMed ID: 36249424
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.
Rukanskienė D; Veikutis V; Jonaitienė E; Basevičiūtė M; Kunigiškis D; Paukštaitienė R; Čepulienė D; Poškienė L; Boguševičius A
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183080
[No Abstract] [Full Text] [Related]
15. This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients.
van Hemert AKE; van Duijnhoven FH; Vrancken Peeters MTFD
Breast; 2023 Oct; 71():89-95. PubMed ID: 37562108
[TBL] [Abstract][Full Text] [Related]
16. Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI.
Kim H; Park W; Kim SS; Ahn SJ; Kim YB; Kim TH; Kim JH; Choi JH; Park HJ; Chang JS; Choi DH
Breast; 2020 Feb; 49():63-69. PubMed ID: 31734590
[TBL] [Abstract][Full Text] [Related]
17. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
Toi M; Benson JR; Winer EP; Forbes JF; von Minckwitz G; Golshan M; Robertson JF; Sasano H; Cole BF; Chow LW; Pegram MD; Han W; Huang CS; Ikeda T; Kanao S; Lee ES; Noguchi S; Ohno S; Partridge AH; Rouzier R; Tozaki M; Sugie T; Yamauchi A; Inamoto T
Breast Cancer Res Treat; 2012 Dec; 136(3):919-26. PubMed ID: 23143284
[TBL] [Abstract][Full Text] [Related]
18. Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review.
Xu R; Li J; Zhang Y; Jing H; Zhu Y
Medicine (Baltimore); 2017 Dec; 96(51):e9312. PubMed ID: 29390502
[TBL] [Abstract][Full Text] [Related]
19. Occult breast carcinoma presenting with axillary lymph node metastases: follow-up of eleven patients.
Matsuoka K; Ohsumi S; Takashima S; Saeki T; Aogi K; Mandai K
Breast Cancer; 2003; 10(4):330-4. PubMed ID: 14634511
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of patients with axillary lymph node metastases from occult breast cancer: analysis of multicenter data.
Kim H; Park W; Kim SS; Ahn SJ; Kim YB; Kim TH; Kim JH; Choi JH; Park HJ; Chang JS; Choi DH
Radiat Oncol J; 2021 Jun; 39(2):107-112. PubMed ID: 34619827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
